Sorted By:

Relevance


Medicines in Development for Skin Diseases 2011 Report

PhRMA  |  Report

America’s biopharmaceutical research companies are currently developing 277 medicines to help the more than 100 million Americans—one-third of the U.S. population—afflicted with at least one skin disease, ranging from acne to melanoma. All of the medicines are either in clinical trials or awaitin...
https://www.phrma.org/report/medicines-in-development-for-skin-diseases

Fighting Leukemia and Lymphoma

From Hope To Cures  |  From Our Network

More Than 240 Medicines in Development for Leukemia, Lymphoma and Other Blood Cancers
http://www.fromhopetocures.org/fighting-leukemia-and-lymphoma

Clarity around anti-kickback statute needed to promote innovative payment arrangements

PhRMA  |  Blog Post

Learn more at www.phrma.org/value-collaborative.
http://catalyst.phrma.org/clarity-around-anti-kickback-statute

Media Contacts

PhRMA  |  From PhRMA

If you are a member of the press, please contact: 202-835-3460newsroom@phrma.orgTwitter: @PhRMA
https://www.phrma.org/press-room/media-contacts

Week in Review: The latest from PhRMA

PhRMA  |  Blog Post

 This, and new findings showing that 340B hospitals account for over half of Part B drug reimbursements but underperform in Medicare hospital outpatient revenue, further underscores the need for congressional action on eligibility criteria.
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-february-12-2016

New First-of-Its-Kind Study Shows Growing Share of Medicine List Prices Going to Rebates and Supply Chain

PhRMA  |  Press Release

Payers are increasingly demanding higher rebates to stay on formulary at the same time that there has been an increase in mandatory rebates in Medicaid and the rapidly growing 340B program.
https://www.phrma.org/press-release/new-first-of-its-kind-study-shows-growing-share-of-medicine-list-prices-going-to-rebates-and-supply-chain

Exploring the new era of medicine

PhRMA  |  Blog Post

This event, and the series of events to follow, will convene leading voices to explore the state of modern medicine and the science that has revolutionized treatment options.
http://catalyst.phrma.org/exploring-the-new-era-of-medicine-0

Medicines in Development for Leukemia & Lymphoma 2015 Report

PhRMA  |  Report

Each year, more than 162,000 Americans are diagnosed with a blood cancer—accounting for more than 9 percent of all new cancer diagnoses. Major types of blood cancers include leukemia, lymphoma and myeloma....
https://www.phrma.org/report/medicines-in-development-for-leukemia-and-lymphoma-2015-report

Medicare Monday: Open enrollment is here again

PhRMA  |  Blog Post

study found that beneficiaries can save $400 to $600 per year on average by reviewing and switching plans.
http://catalyst.phrma.org/medicare-monday-open-enrollment-is-here-again

Policy Solutions

PhRMA  |  Policy Paper

Addressing Market Distortions We need to address market distortions like the rapidly growing 340B program or the risk adjuster for commercial insurance that does not account for prescription drug costs. 
https://www.phrma.org/policy-paper/policy-solutions

Why reauthorization of PDUFA matters

PhRMA  |  Blog Post


http://catalyst.phrma.org/why-reauthorization-of-pdufa-matters

Part D

PhRMA  |  From PhRMA

According to figures from the Congressional Budget Office, total program costs are $349 billion (or 45 percent) less than initial 2004-2013 projections.
https://www.phrma.org/advocacy/medicare/partd

Week in Review: The Latest from PhRMA

PhRMA  |  Blog Post

Find out more about why low rates of charity care is just one of many reasons the 340B program needs reform.
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-september-18-2015

Week in Review: The Latest from PhRMA

PhRMA  |  Blog Post

Check it out here.
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-september-11-2015

Fighting Neurological Disorders

From Hope To Cures  |  From Our Network

Biopharmaceutical companies are developing more than 400 new medicines to prevent and treat neurological disorders.
http://www.fromhopetocures.org/neuro

Medicare Monday: Positive impact of Part D on America’s seniors

PhRMA  |  Blog Post

Longer Life Expectancy: Since Part D was implemented in 2006, nearly 200,000 beneficiaries have lived at least 1 year longer.
http://catalyst.phrma.org/medicare-monday-positive-impact-of-part-d-on-americas-seniors

Research in Virginia

PhRMA  |  Research In Your Backyard

Of the more than 3,400 clinical trials, more than 1,500 target the nation’s six most debilitating chronic diseases—asthma, cancer, diabetes, heart disease, mental illnesses and stroke.
https://www.phrma.org/research-in-your-backyard/research-in-virginia

Building on the promise of personalized medicine

PhRMA  |  Blog Post

Although there were only 13 FDA-approved personalized medicines in 2006, today there are more than 140.
http://catalyst.phrma.org/building-on-the-promise-of-personalized-medicine

Fighting Skin Diseases

From Hope To Cures  |  From Our Network

Biopharmaceutical Research Companies Are Developing Nearly 300 Medicines to Treat Diseases of the Skin
http://www.fromhopetocures.org/fighting-skin-diseases

New data put medicine costs and spending in context

PhRMA  |  Blog Post

Get more at PhRMA.org/cost.
http://catalyst.phrma.org/new-data-put-medicine-costs-and-spending-in-context

Fighting Infectious Disease

From Hope To Cures  |  From Our Network

America’s biopharmaceutical companies are developing nearly 400 new medicines for infectious diseases.
http://www.fromhopetocures.org/fighting-infectious-disease

Week in Review: The Latest from PhRMA

PhRMA  |  Blog Post

Castellani sent a statement for the record to the Energy and Commerce Health Subcommittee on the hearing being held on the 340B program.
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-march-27-2015

Week in Review: The Latest from PhRMA

PhRMA  |  Blog Post

Learn more about how patients and payers are impacted.
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-september-25-2015

Week in Review: The Latest from PhRMA

PhRMA  |  Blog Post

Learn more about the history of contract pharmacy arrangements and why a policy change in 2010 led to a dramatic increase in the volume of contract pharmacies.
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-october-2-2015

Week in Review: The latest from PhRMA

PhRMA  |  Blog Post

Find out more about how the 340B program may not be reaching those in need.
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-april-29-2016

You have reviewed the first 125 results out of 427. Each page contains 25 results. You're on page 5.

prev 1 2 3 4 5 6 next